Nitrazepam and the Subconscious SiR,-We must apologize for our delay in replying to the letter from Dr. Frances Taylor (13 January, p. 113) regarding her findings on the use of nitrazepam. As she mentioned, the drug may in certain cases give the patient vivid and painful nightmares, which disappear after a certain time. We were very pleased to hear her explanation on the lines of the good old Freudian theory of dreams and the psychotherapeutic effect of dreaming. Nitrazepam might thus be regarded as a catalyst, favouring the natural process of restoring psychic equilibrium.
This hypothetical statement should not be greeted with surprise when we consider that nitrazepam belongs to the chemical class of the benzodiazepines, which are known to have the property of weakening the inhibiting power of the superego (please allow us to go on using the Freudian way of thinking and talking). But let us go further along the path that Dr. Taylor has opened up. It is generally accepted that most cases of insomnia are of psychic or psychopathological origin. This means that insomniacs are prone to a certain psychic tension, which may be attributed to the subconscious persistence of unhealed psychic traumata or unresolved psychic conflicts. The authors have neglected the fundamental difficulty in diagnostic medicine of defining in unequivocal terms the criteria which they propose to use to define the disease which they are trying to identify. Their only coament on this problem is to state that "on completion of all investigations the patients were allocated to three populations (thyrotoxic, euthyroid, or hypothyroid) by two doctors who collated all the test parameters." They then proceed to evaluate t;he discriminant value of these same parameters in arriving at the correct diagnosis. The possibility of bias by the two doctors must be self-evident.
I would also object to the description of the diagnostic methods recommended in the papers of Crooks et al. 1 and Billewicz et al.2 as "clinical questionnaires" since they, in fact, attempted to apply statistical techniques to conventional clinical observations wvth only minimal, though important, constrictions on the method of obtaining the information.
TIhough I accept the conclusions of the authors that the combination of serum protein-bound iodine and triiodothyronine uptake tests is at present the most effective routine laboratory-based method of arriving at the diagnosis of thyrotoxicosis, I regret their implied denigration of clinical evidence as part of the diagnostic process. I also regret that they did not include the results of a therapeutic trial of the various methods of treating thyrotoxicosis in their,paper since, in terms of the practicality of patient care, this is a more acceptable diagnostic criterion than that provided. 
Administration of Disodium Cromoglycate
to Young Children SIR,-The role of disodium cromoglycate (DSG) is now well established in the prophylaxis of asthma. However, few children under the age of 3 to 4 years are able to use adequately the Spinhaler. We have now used for several years a simple and effective method of administering this drug to these young children. Ten milligrames of DSG is dissolved in 2 ml of saline and inhaled as a mist via a face mask and Bennett twin-jet nebulizer which is driven by an air compressor pump with an output of 6 1./min. The drug is given three or four times a day and usually 0-25 ml of 2% orciiprenaline is included in the inhalation. Children readily adapt to this method as they can play or look at books during the 10-15 minutes of treatment.
So far 21 patients, all with moderately severe asthma clinically, have been treated. Five under the age of 1 year did not receive any obvious benefit, but most of t-he others seemed to be helped. It has not been possible to obtain objective measurements of improved pulmonary function in these children because of their age, and a controlled trial was not conducted. Our clinical impression was that the frequency and severity of the wheezing episodes in the children over 1 year were much reduced after the introduction of DSG to the therapeutic regimen. Most of the children were having inhalations of orciprenaline alone before starting treatment with DSG. In only two of the 21 has corticosteroid treatment been necessary. Before starting DSG we felt that the majority of these patients would need long-term corticosteroidss.
We would suggest that nebulized DSG is a useful therapeutic agent in children with is often difficult to diagnose when in a mild degree, and also in confirming that the serum thyroid-stimulating hormone (TSH) level appears at present to be the most sensitive laboratory index of thyroid failure. TSH assay is as yet available only in a few centres, however, and it is probable that measurements of thyroid hormone levels in blood (thyroxine, free thyroxine, or free thyroxine index) will continue to be the mainstay of routine laboratory diagnosis of hypothyroidism in most units for some time yet. Measurement of free thyroxine or a free thyroxine indexl13 is thought to give better diagnostic discrimination than serum protein-
